SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

Clinical trial NCT04880174 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04880174
Sponsor: Universitair Ziekenhuis Brussel
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

SARS-CoV Infection

Start date: 2021-03-22
Primary completion: 2028-07-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.